Induced Pluripotent Stem Cells
"Induced Pluripotent Stem Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS.
| Descriptor ID |
D057026
|
| MeSH Number(s) |
A11.872.040.500 A11.872.700.500
|
| Concept/Terms |
Fibroblast-Derived Induced Pluripotent Stem Cells- Fibroblast-Derived Induced Pluripotent Stem Cells
- Fibroblast Derived Induced Pluripotent Stem Cells
- Fibroblast-Derived IPS Cells
- Cell, Fibroblast-Derived IPS
- Cells, Fibroblast-Derived IPS
- Fibroblast Derived IPS Cells
- Fibroblast-Derived IPS Cell
- IPS Cell, Fibroblast-Derived
- IPS Cells, Fibroblast-Derived
|
Below are MeSH descriptors whose meaning is more general than "Induced Pluripotent Stem Cells".
Below are MeSH descriptors whose meaning is more specific than "Induced Pluripotent Stem Cells".
This graph shows the total number of publications written about "Induced Pluripotent Stem Cells" by people in this website by year, and whether "Induced Pluripotent Stem Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 2 | 1 | 3 |
| 2011 | 5 | 0 | 5 |
| 2012 | 1 | 0 | 1 |
| 2013 | 4 | 1 | 5 |
| 2014 | 6 | 3 | 9 |
| 2015 | 3 | 6 | 9 |
| 2016 | 6 | 6 | 12 |
| 2017 | 12 | 3 | 15 |
| 2018 | 8 | 6 | 14 |
| 2019 | 8 | 8 | 16 |
| 2020 | 6 | 7 | 13 |
| 2021 | 5 | 9 | 14 |
| 2022 | 8 | 1 | 9 |
| 2023 | 9 | 0 | 9 |
| 2024 | 11 | 6 | 17 |
| 2025 | 9 | 8 | 17 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Induced Pluripotent Stem Cells" by people in Profiles.
-
HydroMEA: A 3D Hydrogel-Based Microfluidic Device to Study Electrophysiology for Myelinated Nerve-on-Chip. Adv Healthc Mater. 2026 Oct; 15(37):e71655.
-
Stem Cell-Derived Cardiac and Conduction System Cells for Heart Regeneration and Repair: Current Progress and Future Directions. J Am Heart Assoc. 2026 09; 15(17):e050981.
-
Pathogenic myeloid phenotypes drive disease pathology in a novel human neurohistiocytosis model. Blood. 2026 07 23; 148(4):433-449.
-
Derivation of elephant induced pluripotent stem cells. Nat Methods. 2026 Jul; 23(7):1399-1410.
-
Modulating alternative splicing of MECP2 is a potential therapeutic strategy for Rett syndrome. Sci Transl Med. 2026 Mar 04; 18(839):eadq4529.
-
Aberrant nuclear pore complex degradation contributes to neurodegeneration in VCP disease. Neuron. 2026 Mar 04; 114(5):850-867.e8.
-
Generation of iPSCs (RFSCi007-A, RFSCi008-A) from a patient with early-onset bilateral drusen and a healthy sibling for retinal disease modeling. Stem Cell Res. 2025 Dec; 89:103862.
-
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease. Blood. 2025 Oct 23; 146(17):2047-2062.
-
Derivation of pluripotent stem cell lines (RFSCi005-A, RFSCi006-A) from siblings harboring identical high-risk complement variants with discordant age-related macular degeneration. Stem Cell Res. 2025 Dec; 89:103852.
-
Engineered 3D immuno-glial-neurovascular human miBrain model. Proc Natl Acad Sci U S A. 2025 Oct 21; 122(42):e2511596122.